Member of Lyonbiopole
The goal of Prediction BioSciences is to discover, develop, and bring to patients therapeutics and diagnostics in the field of stroke and neurodegenerative diseases.
While the Company maintains R&D collaborations with numerous academic and industry partners throughout Europe and Asia, it launched Mosaic Neurosciences (Epalinges, CH) in May 2022 as a new R&D laboratory dedicated to neurodegenerative disorders such as Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS).
Strategic application domain: In Vitro diagnostic
Application market: Cardiology, Neurology & Mental Health Disorders
Type of activity: Diagnostics, Therapeutics, Pharma or Biotech
Technologies: Antibodies - Protein - Peptide, Drug delivery device & Technologies, Screening methods or services
Created on jan. 11th, 2010 - 3 employees
Address
Bioparc Laennec
60A avenue Rockfeller 69008 Lyon
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.